Finally, we show that the promoter regions of ID2 and ID4 display decreased methylation in chronically demyelinated MS lesions, resulting in a higher expression of both genes, which could represent a potential key factor in the impaired differentiation capacity of progressive MS patients. Here, ID4 is linked to myeloid sarcoma.